(Q39583555)

13 September 2017

1 reference

title

Post-mortem neurochemistry of schizophrenia (English)

1 reference

13 September 2017

1 reference

0 references

Reynolds GP

1

1 reference

13 September 2017

language of work or name

English

0 references

publication date

1 November 1988

1 reference

13 September 2017

published in

Psychological Medicine

1 reference

13 September 2017

volume

18

1 reference

13 September 2017

issue

4

1 reference

13 September 2017

page(s)

793-797

1 reference

Peptides, the limbic lobe and schizophrenia

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700009715

7 January 2021

DOPAMINE RECEPTOR ASYMMETRY IN SCHIZOPHRENIA

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700009715

7 January 2021

Brain catecholamines in schizophrenia -- a good case for noradrenaline.

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700009715

7 January 2021

Psychosis and temporal lobe epilepsy. A controlled investigation.

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700009715

7 January 2021

Postmortem evidence of structural brain changes in schizophrenia. Differences in brain weight, temporal horn area, and parahippocampal gyrus compared with affective disorder

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700009715

7 January 2021

Neuropharmacology: Pathophysiology of schizophrenia — causal role for dopamine or noradrenaline?

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700009715

7 January 2021

Increased concentrations and lateral asymmetry of amygdala dopamine in schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700009715

7 January 2021

Dopamine receptor subtype imbalance in schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700009715

7 January 2021

Des-tyrosyl-gamma-endorphin in schizophrenia: a double-blind trial in 13 patients

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700009715

7 January 2021

Asymmetric rotational (circling) behavior, a dopamine-related asymmetry: preliminary findings in unmedicated and never-medicated schizophrenic patients

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700009715

7 January 2021

Dopamine-β-Hydroxylase Deficits in the Brains of Schizophrenic Patients

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700009715

7 January 2021

Brain tryptophan metabolism in schizophrenia: A post mortem study of metabolites on the serotonin and kynurenine pathways in schizophrenic and control subjects

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700009715

7 January 2021

Norepinephrine in Chronic Paranoid Schizophrenia: Above-Normal Levels in Limbic Forebrain

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700009715

7 January 2021

Increased brain dopamine and dopamine receptors in schizophrenia.

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700009715

7 January 2021

Neurotransmitter Receptors in Frontal Cortex of Schizophrenics

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700009715

7 January 2021

Coupling of Dopamine D 1 Recognition Sites with Adenylate Cyclase in Nuclei Accumbens and Caudatus of Schizophrenics

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700009715

7 January 2021

Antipsychotic Drug Action in Schizophrenic Patients: Effect on Cortical Dopamine Metabolism After Long-Term Treatment

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700009715

7 January 2021

Prenatal developmental disturbances in the limbic allocortex in schizophrenics

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700009715

7 January 2021

Gamma-aminobutyric acid in the brain in schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700009715

7 January 2021

Glutamic-acid decarboxylase in schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700009715

7 January 2021

Increased dopamine-receptor sensitivity in schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700009715

7 January 2021

Changes in rat striatal dopamine turnover and receptor activity during one years neuroleptic

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700009715

7 January 2021

Bimodal Distribution of Dopamine Receptor Densities in Brains of Schizophrenics

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700009715

7 January 2021

Regional sensitivity of primate brain dopaminergic neurons to haloperidol: alterations following chronic treatment

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700009715

7 January 2021

Possible Etiology of Schizophrenia: Progressive Damage to the Noradrenergic Reward System by 6-Hydroxydopamine

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700009715

7 January 2021

Chronic neuroleptic treatment enhances neurotensin receptor binding in human and rat substantia nigra

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700009715

7 January 2021

Tritiated LSD Binding in Frontal Cortex in Schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700009715

7 January 2021

Reduced cholecystokinin-like and somatostatin-like immunoreactivity in limbic lobe is associated with negative symptoms in schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700009715

7 January 2021

[3H]SCH 23390 labeled D1 dopamine receptors are unchanged in schizophrenia and Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700009715

7 January 2021

10.1017/S0033291700009715

Identifiers

DOI

0 references

1 reference